Eargo - Funding, Financials, Valuation, Investors - Cointime

比特币 ¥818,935.24 +1.95%
以太坊 ¥25,172.94 +4.00%
币安币 ¥5,400.31 +2.99%
Optimism ¥4.73 +5.49%
Arbitrum ¥2.76 +5.53%
Solana ¥1,170.37 +4.02%
Polygon ¥1.56 +2.77%
Cosmos ¥30.75 +5.88%
Avalanche ¥154.27 +4.21%

比特币 ¥818,935.24 +1.95%
以太坊 ¥25,172.94 +4.00%
币安币 ¥5,400.31 +2.99%
Optimism ¥4.73 +5.49%
Arbitrum ¥2.76 +5.53%
Solana ¥1,170.37 +4.02%
Polygon ¥1.56 +2.77%
Cosmos ¥30.75 +5.88%
Avalanche ¥154.27 +4.21%

Eargo

company

Investors

Number of Lead Investors

Number of Investors

7

19

Eargo is funded by 19 investors. Patient Square Capital and Gilde Healthcare are the most recent investors.

Investor Name	Lead Investor	Funding Round
Patient Square Capital	Yes	Post-IPO Debt
Gilde Healthcare	Yes	Series E
Longitude Capital	Yes	Series E
Future Fund	Yes	Series D
Charles and Helen Schwab Foundation	-	Series E
Nan Fung Life Sciences	-	Series E
New Enterprise Associates	-	Series E
Maveron	-	Series D
Schwab Institutional	-	Series D
Charles Schwab Corporation	-	Series C
Peterson Ventures	-	Series C
Dolby Family Ventures	-	Series B
StartX (Stanford-StartX Fund)	-	Series B
Birchmere Ventures	-	Series A
Crosslink Capital	-	Series A
Farzad (Zod) Nazem	-	Series A
Montage Ventures	-	Series A
Pierre Lamond	-	Series A
Red Sea Ventures	-	Series A